SPONSOR
Hubei Cancer Hospital
Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: Breast NeoplasmsHormone Receptor-Positive Breast CancerAbemaciclibAbemaciclib-related DiarrheaDrug-induced DiarrheaGastrointestinal Microbiome (Focus)MicrobiomeNausea With Vomiting Chemotherapy-Induced
Hubei Cancer Hospital is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Breast Neoplasms, Hormone Receptor-Positive Breast Cancer, Abemaciclib, Abemaciclib-related Diarrhea.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hubei Cancer Hospital
How many clinical trials has Hubei Cancer Hospital sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Hubei Cancer Hospital, of which 2 are actively recruiting participants. These trials cover conditions including Breast Neoplasms, Hormone Receptor-Positive Breast Cancer, Abemaciclib. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hubei Cancer Hospital research focus on?
Hubei Cancer Hospital clinical trials span Breast Neoplasms, Hormone Receptor-Positive Breast Cancer, Abemaciclib, Abemaciclib-related Diarrhea, Drug-induced Diarrhea, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Hubei Cancer Hospital clinical trial?
To participate in a Hubei Cancer Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hubei Cancer Hospital trials with current recruitment status updated daily.
Clinical Trials by Hubei Cancer Hospital
NCT07264998
Recruiting
Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea
Breast Neoplasms
NCT06080880
Recruiting
Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade
Nausea With Vomiting Chemotherapy-Induced
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology